89785-84-2 (他唑巴坦钠,Tazobactam Sodium Salt)

他唑巴坦钠;冻干无菌粉;泰唑巴坦钠;[2S-(2a,3b,5a)]-3-甲基-7-氧代-3-(1H-1,2,3-三氮唑-1-基甲基)-4-硫代-1-氮杂双环[3,2,0]庚烷-2-羧酸钠 4,4-二氧化物;三唑巴坦钠;他唑巴坦酸钠盐;他唑巴坦钠 (标准品);他唑巴坦钠 GMP;[2S-(2α,3β,5α)]-3-甲基-7-氧;4-羟基芬司匹利;他唑巴坦钠,AR;他唑巴坦钠标准品;

[2s-(2a,3b,5a)]-3-methyl-7-oxo-3(1h,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide sodium salt;[2S-(2ALPHA, 3BETA, 5ALPHA)]-3-METHYL-7-OXO-3(1H,2,3-TRIAZOL-1-YLMETHYL)-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID 4,4-DIOXIDE SODIUM SALT;CL-298741 SODIUM SALT;TAZOBACTAM SODIUM;TAZOBACTAM SODIUM SALT;YTR-830H SODIUM SALT;2-alpha-methyl-2-beta-(1,2,3-triazol-1-ylmethyl)penam-3-alpha-carboxylicacid;3-methyl-7-oxo-3-(1h-1,2,3-triazol-1-ylmethyl)-,4,4-dioxide,sodiumsalt,(2s-(2-alpha,3-beta,5-alp4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylicaci;4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylicacid,3-methyl-7-oxo-3-(1h-1,2,3;cl307579;-triazol-1-ylmethyl)-,4,4-dioxide,sodiumsalt,(2s-(2-alpha,3-beta,5-alpha));ytr830;(2S,3S,5R)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid 4,4-dioxide Sodium Salt;CL-30757;[2s-(2α,3β,5α)]-3-methyl-7-oxo-3(1h,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide;Piperacillin sodium salt;PHARMA-0692;Tazobactam Sodium Sa;SODIUM;TAZOBACTAMACID;1H-1,2,3-Triazole, 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid deriv. (ZCI);4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt, (2S,3S,5R)- (9CI);4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt, [2S-(2α,3β,5α)]- (ZCI);CL 307579;YTR 830;AS-56873;Q27158392;SCHEMBL259991;T-1446;sodium (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-[(1H-1,2,3-triazol-1-yl)methyl]-4lambda(6)-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;TAZOBACTAM SODIUM SALT [MI];TAZOBACTAM SODIUM [WHO-DD];YP-14;AC-32478;Tox21_111584_1;Sodium; (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-[1,2,3]triazol-1-ylmethyl-4lambda*6*-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylate;DTXCID6026030;Sodium (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate, 4,4-dioxide;Tox21_111584;sodium (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-[1,2,3]triazol-1-ylmethyl-4lambda6-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylate;Sodium(2S,3S,5R)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate4,4-dioxide;RFMIKMMOLPNEDG-QVUDESDKSA-M;AKOS016843926;CL-307579;Sodium (2S,3S,5R)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide;D03707;89785-84-2 (sodium);CS-W009884;Tazobactam sodium salt, Antibiotic for Culture Media Use Only;sodium;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;Tazobactam sodium (JAN/USAN);ZERBAXA COMPONENT TAZOBACTAM SODIUM;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt, (2S,3S,5R)-;CL 307,579;YTR-830;tazobactum;2-alpha-Methyl-2-beta-(1,2,3-triazol-1-ylmethyl)penam-3-alpha-carboxylic acid sodium salt;Tazobactam (as sodium);AKOS015962921;UNII-UXA545ABTT;AC-18978;TAZOBACTAM SODIUM [JAN];NCGC00159340-05;Tazobactam acid Sodium, Tazobactamum Sodium;UXA545ABTT;ZOSYN COMPONENT TAZOBACTAM SODIUM;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt, (2S-(2alpha,3beta,5alpha))-;Tazobactam sodium [USAN];Tazobactam sodium salt, analytical standard;CHEBI:85192;Tazobactum sodium;DTXSID8046030;89785-84-2;Sodium (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, 4,4-dioxide;HY-W009168;Tazobactam sodium salt, beta-lactamase inhibitor;TAZOBACTAM SODIUM [VANDF];CAS-89785-84-2;TAZOBACTAM SODIUM [ORANGE BOOK];Tazobactam (sodium);NCGC00159340-02;G12877;TAZOBACTAM SODIUM [MART.];BDBM50157692;CL-298741;CHEMBL1439;

MFCD00917472

ZUNWFYFXHGWFRA-QVUDESDKSA-N

1S/C10H12N4O5S.Na/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19;/h2-3,7-8H,4-5H2,1H3,(H,16,17);/t7-,8+,10+;/m1./s1

C(N1N=NC=C1)[C@@]1(S(=O)(=O)[C@@H]2CC(N2[C@H]1C(=O)O)=O)C.[Na]

2934999090

不可逆竞争性β－内酰胺酶抑制剂。

MFCD00917472